Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/1996
12/19/1996WO1996040875A1 Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
12/19/1996WO1996040874A1 Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
12/19/1996WO1996040873A1 Standardized, primary osteoblast cell cultures taken from patients suffering from osteoporosis, and the use of these cell cultures in the diagnosis of osteoporosis and for testing potential osteoporosis therapeutic agents
12/19/1996WO1996040872A1 Bile duct progenitor cells and methods of use
12/19/1996WO1996040871A1 Bioartificial organs comprising open pored foam-like membranes
12/19/1996WO1996040865A1 Replacement therapy for dental caries
12/19/1996WO1996040857A1 Methods and devices for the removal of psoralens from blood products
12/19/1996WO1996040829A1 Crosslinkable polypeptide compositions
12/19/1996WO1996040782A1 Separation of hemoglobin on hydroxyapatite using hplc
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040714A1 GLYCINE AND PHASEOLUS α-D-GALACTOSIDASES
12/19/1996WO1996040406A1 Blood processing systems and methods for collecting mono nuclear cells
12/19/1996WO1996040403A1 Blood processing systems and methods which restrict in flow of whole blood to increase platelet yields
12/19/1996WO1996040402A1 Enhanced yield blood processing systems with angled interface control surface
12/19/1996WO1996040401A1 Blood collection system deriving instantaneous component yield
12/19/1996WO1996040399A1 Blood processing systems controlled by apparent hematocrit
12/19/1996WO1996040272A1 Aav transduction of myoblasts
12/19/1996WO1996040270A1 In vitro packaging of adeno-associated virus dna
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040244A1 Antibodies to porcine cd34 positive cells and uses therefor
12/19/1996WO1996040242A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/19/1996WO1996040240A1 Helper virus-free aav production
12/19/1996WO1996040237A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
12/19/1996WO1996040234A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040233A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040222A1 Hemodilution facilitated by monitoring oxygenation status
12/19/1996WO1996040218A1 Methods for increasing hematopoietic cells
12/19/1996WO1996040179A1 Method of improving animal health
12/19/1996WO1996040178A1 Use of co-localized islets and sertoli cells in xenograft cellular transplants
12/19/1996WO1996040177A1 Modified animal lung surfactant and its therapeutic use
12/19/1996WO1996040175A1 Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures
12/19/1996WO1996040174A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996WO1996040173A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996WO1996040172A1 Compositions and methods for improving autologous fat grafting
12/19/1996WO1996040081A2 Oral delivery of gene constructs
12/19/1996WO1996040071A1 Method for the manufacture of minimal volume capsules containing biological material
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039979A1 Apparatus and methods for cell isolation and collection
12/19/1996WO1996039842A1 Moist bacteriocin disinfectant wipes and methods of using the same
12/19/1996WO1996039840A2 Treatment of soil and plants with a composition containing bacillus laterosporus
12/19/1996WO1996039816A1 Method of inactivation of viral and bacterial blood contaminants
12/19/1996WO1996039815A1 Psoralen-binding polymers
12/19/1996WO1996031237A3 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
12/19/1996DE19521705A1 Immunogenes Konstrukt, Verfahren zu dessen Herstellung und Verwendung als Vakzine An immunogenic construct, a process for its preparation and use as a vaccine
12/19/1996CA2224226A1 Immunoprotective barrier for transplantation of cells
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224071A1 Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures
12/19/1996CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996CA2223889A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996CA2223734A1 Compositions and methods for improving autologous fat grafting
12/19/1996CA2223717A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996CA2223610A1 Nucleic acid respiratory syncytial virus vaccines
12/19/1996CA2223557A1 Method of improving animal health
12/19/1996CA2223246A1 Cell line producing analgesic compounds for treating pain
12/19/1996CA2223101A1 Standardized, primary osteoblast cell cultures from osteoporotic patients and their use in the diagnosis of osteoporosis and in testing potential osteoporosis therapeutic agents
12/19/1996CA2223046A1 Methods for increasing hematopoietic cells
12/19/1996CA2222761A1 Recombinant bacterial system with environmentally limited viability
12/19/1996CA2222534A1 In vitro packaging of adeno-associated virus dna
12/19/1996CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996CA2222066A1 Hemodilution facilitated by monitoring oxygenation status
12/19/1996CA2221733A1 Method of inactivation of viral and bacterial blood contaminants
12/19/1996CA2221625A1 Modified animal lung surfactant and its therapeutic use
12/19/1996CA2221511A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/19/1996CA2221323A1 Oral delivery of gene constructs
12/19/1996CA2220957A1 Glycine and phaseolus .alpha.-d-galactosidases
12/19/1996CA2218896A1 Bile duct progenitor cells and methods of use
12/19/1996CA2195188A1 Enhanced yield blood processing systems with angled interface control surface
12/19/1996CA2195070A1 Blood processing systems and methods which restrict in flow of whole blood to increase platelet yields
12/19/1996CA2195069A1 Blood collection system deriving instantaneous component yield
12/18/1996EP0748870A2 Oncostatin M induced hematopoiesis
12/18/1996EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them
12/18/1996EP0748631A2 Viral vaccines
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
12/18/1996EP0748375A1 Selective virus culture
12/18/1996EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
12/18/1996EP0609242B1 New thrombin-inhibiting protein isolated from ticks
12/18/1996CN1138295A A novel tumor suppressor gene
12/18/1996CN1137916A Medicine for treating burn and scald and its preparation method
12/18/1996CN1137910A Snake extract oral liquor and its preparation method
12/18/1996CN1137898A Shark cartilage capsule and its preparation technology
12/18/1996CN1137897A Animal blood hirudo hydrolytic method and hirudo hydrolytic blood
12/17/1996US5585503 Compounds for the photodecontamination of pathogens in blood
12/17/1996US5585365 Antiviral polysaccharide
12/17/1996US5585362 Adenovirus vectors for gene therapy
12/17/1996US5585350 Thrombin-inhibitory protein from ticks
12/17/1996US5585349 Method of treating viral infections
12/17/1996US5585267 Hemidesmosome formation-inducing protein coated on appliance
12/17/1996US5585117 Use of a mixture of calcium hydroxide and oleum pedum tauri for collagen reformation in vivo
12/17/1996US5585106 Nonspecific defense mechanism; administering phagocytosable particles of a particular size to enhance macrophage oxidizing activity; pretreatment for surgery, prosthetics; anticancer agents; aids
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996US5585007 Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
12/17/1996CA2091980C Natural pulmonary surfactants and lipid extracts thereof
12/12/1996WO1996039530A2 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof
12/12/1996WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
12/12/1996WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039496A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 1259